Vitamin K2 – Capsule
- Helps your bones use calcium more effectively
- Supports normal blood clotting
- Supports heart health
- Provides science-based ratios of MK-4 and MK-7 for greater effectiveness
$26.81 — or subscribe and save 20%
Vitamin K is an essential vitamin needed for cardiovascular, bone and liver health. Vitamin K2 is more effective than vitamin K1, the form found in plants, for these specific health effects. There are two effective and popular forms of Vitamin K2: namely MK-4 and MK-7. While MK-4 is the active form of vitamin K2 used by the body and has been used clinically in Japan for decades with good results, MK-7 has also been shown to provide good results at low doses in a sustained-release manner. AOR’s Vitamin K2 provides a 50/50 blend of MK-4 and MK-7 to ensure the best of both worlds.
The most popular, albeit recently highlighted, use for vitamin K2 is for bone health. Vitamin K, along with vitamin D, is essential for proper calcium absorption and usage in the bones. Vitamin K2 also stimulates the synthesis of proteins that regulate bone growth, and has been shown to reduce the incidence of osteoporotic fractures and improve bone quality.
Vitamin K is also essential to cardiovascular health. It is an important blood clotting factor: without adequate amounts, the risk of bruising and excessive bleeding increases substantially. By the same token, vitamin K enhances calcium absorption from the bloodstream into the bones, preventing arterial calcification and promoting healthy blood vessel function and heart health. Ultimately, Vitamin K2 is an excellent adjunct to conventional osteoporosis medications and is essential for those taking calcium supplements. Vitamin K2 may also be useful for those with a family history of osteoporosis, cardiovascular disease, arterial calcification or for people who bruise or bleed easily.
Driven by research, AOR’s new formulation offers a 50/50 blend of 60 mcg each of both forms of vitamin K2 in order to provide an adequate dose for the absorption benefits of MK-7 while still providing MK-4, which has been successfully clinically studied and used for bone health for decades and is the primary form found in the human body.
Vitamin K2 from AOR™ provides MK-4 and MK-7, the two optimal forms of Vitamin K2 that help maintain bone health. Although it interferes with “blood thinning” medications, it does not cause excessive or abnormal blood clotting.
AOR™ guarantees that all ingredients have been declared on the label. Contains no wheat, gluten, nuts, peanuts, sesame seeds, sulphites, mustard, soy, dairy, eggs, fish, shellfish or any animal byproduct.
Take one capsule daily with food, or as directed by a qualified health care practitioner.
Do not use if taking anticoagulant (“blood thinning”) medications such as warfarin (Coumadin®) or if pregnant or breastfeeding. This product contains a corn derived ingredient, do not use this product if you have such allergy.
- Bone health
- Calcium absorption
- Cardiovascular health
The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide or replace medical advice to individuals from a qualified health care professional. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes.
Non-medicinal Ingredients: microcrystalline cellulose, sucrose, acacia gum, corn starch, medium chain triglycerides and tricalcium phosphate. Capsule: hypromellose.
In a 2006 review, authors Iwamoto et al. discussed the evidence that vitamin K2 reduces the incidence of fractures within the spinal vertebrae in postmenopausal women with osteoporosis. Although K2 has only modest effects on bone mineral density in these women, researchers have found that combining K2 with conventional osteoporosis medication (bisphosphonates), treatment may be more effective than with medication alone.
In a 2013 clinical trial, 244 healthy postmenopausal women were given either 180mcg of vitamin K2 or placebo daily for three years. Those given K2 showed decreased declines in bone mineral density (slower bone loss) in the hip and low back spine.
In a 2015 double-blind, randomized, controlled trial, researchers sought out to determine the effect of vitamin K2 on cardiovascular health. 244 healthy postmenopausal women were randomised to receive either 180mcg of vitamin K2 (MK-7) or placebo for 3 years. At the end of the treatment period the group that had been on K2 had significantly decreased arterial stiffness. The effect was greatest in women who started the study with high levels of stiffness, as K2 was able to decrease those measurements by 50% compared to placebo.